GLP1R and type 2 diabetes mellitus: By constructing an analytical framework integrating “mechanism-drug-strategies,” we explore mechanisms of action and clinical effects of multiple medications (insulin, metformin, sodium–glucose cotransporter-2 inhibitors, and glucagon-like peptide-1 [GLP-1] receptor agonists) for T2DM remission and analyze synergistic effects of combination therapies.